Azienda Ospedaliera Universitaria San Luigi Gonzaga

Orbassano 10043

1 studies enrolling now · 4 studies all time

What they study most

Limited Stage Small Cell Lung Cancer, Metastatic Castration-resistant Prostate Cancer, Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC)

Studies at this site

• A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer — Recruiting now
• Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute) — Running, not enrolling
• Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) — Running, not enrolling
• Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer — Running, not enrolling